Skip to main content
Article thumbnail
Location of Repository

Nuclear Medicine in the Management of Patients with Well-differentiated Thyroid Carcinoma

By Wen-sheng Huang, Yaoh-shiang Lin, Sing-yung Wu, Ann Nucl and Med Sci


Management for patients with well-differentiated thyroid cancer (DTC) remains clinically controversial and requires a multifaceted approach. The approach should be multidisciplinary. In general, when patients are highly suspected to have DTC, surgeons carry out an appropriate removal of thyroid tissue and lymph nodes. Pathologists evaluate the type and malignancy of the tumor; extend of extra thyroidal and vascular invasion and lymph node involvement. In most of the cases, post-operative radioiodine-131 ( 131 I) ablation of residual thyroid tissue or metastatic lesions is needed when serum thyroid- stimulating hormone levels are increased. Follow-up 131I whole body scan (WBS) and serum Tg are then performed to monitor therapeutic effects and disease conditions. Correlations are made with other modalities, depending on patients ’ risk analyses an

Year: 2014
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.